Wegovy carries a separate cardiovascular indication for adults with established cardiovascular disease and either obesity or overweight, supported by a trial reporting a primary composite endpoint of 6.5% versus 8% with placebo, hazard ratio 0.80
Is it normal to still feel some hunger on Mounjaro
The three FDA-approved medications for weight loss are injected daily or weekly: liraglutide (GLP-1): once a day semaglutide (GLP-1): once a week injectable tirzepatide (dual GIP/GLP-1): once a week These injectable medications come in prefilled pens or vials with needles and syringes
GLP-1 Patches: Theyre Not What You Think Youve probably seen them advertised on social media: patches claiming to deliver GLP-1 or boost your bodys GLP-1 production
You can do the same thing with GIP, GCG and peptide tyrosine tyrosine, which also play a role in appetite suppression
The compound performed across the board rather than favouring one body type, and the appetite suppression most users felt within the first month was the early sign that the molecule had taken hold